S-Refit
4
5M
3
0.25
- Areas of investment
Summary
The company was established in Europe in Germany. The main office of represented VC is situated in the Regensburg.
The high activity for fund was in 2005. The fund is generally included in less than 2 deals every year. The usual things for fund are deals in the range of 10 - 50 millions dollars.
Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. Among the most successful fund investment fields, there are Biotechnology, Therapeutics. For fund there is a match between the country of its foundation and the country of its the most frequent investments - Germany. Among the various public portfolio startups of the fund, we may underline Isarna Therapeutics, Lophius Biosciences
The typical case for the fund is to invest in rounds with 2-3 participants. Despite the S-Refit, startups are often financed by High-Tech Gru00fcnderfonds, Bayern Kapital GmbH, Global Chance Fund. The meaningful sponsors for the fund in investment in the same round are VRD GmbH, MIG AG, Heidelberg Innovation. In the next rounds fund is usually obtained by MIG AG, wolf biotech gmbh, VRD GmbH.
Investments analytics
Analytics
- Total investments
- 4
- Lead investments
- 0
- Follow on index
- 0.25
- Investments by industry
- Biotechnology (2)
- SaaS (2)
- Software (2)
- Medical (1)
- Therapeutics (1) Show 2 more
- Investments by region
-
- Germany (4)
- Peak activity year
- 2011
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 19
- Group Appearance index
- 0.75
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
Company name | Deal date | Industry | Deal stage | Deal size | Location |
---|---|---|---|---|---|
TM3 Software | 31 May 2011 | Software, SaaS | Early Stage Venture | Bavaria, Regensburg, Germany |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.